Prolyl cis/trans isomerase signalling pathways in cancer

Current Opinion in Pharmacology

Volumn 11, Issue 4, 2011, Pages 281-287

  Theuerkorn, Martin ^a   Fischer, Gunter ^a   Schiene Fischer, Cordelia ^a  

^a Max Plank Research Unit for Enzymology of Protein Folding   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD147 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; CYCLOPHILIN; CYCLOPHILIN B; CYCLOPHILIN D; CYCLOSPORIN A; FK 506 BINDING PROTEIN; JANUS KINASE 2; PEPTIDYLPROLYL ISOMERASE; PEPTIDYLPROLYL ISOMERASE PIN1; PROLACTIN RECEPTOR; RAS PROTEIN; TACROLIMUS;

APOPTOSIS; ARTICLE; BREAST CANCER; CARCINOGENESIS; CATALYSIS; CONFORMATIONAL TRANSITION; HUMAN; ISOMERIZATION; MALIGNANT TRANSFORMATION; NEOPLASM; NONHODGKIN LYMPHOMA; NONHUMAN; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; PROTEIN FOLDING; PROTEOMICS; SKIN CANCER; TUMOR GROWTH;

EID: 80051672574     PISSN: 14714892     EISSN: 14714973     Source Type: Journal    
DOI: 10.1016/j.coph.2011.03.007     Document Type: Review

References (58)

1. G. Fischer, H. Bang, and C. Mech Determination of enzymatic catalysis for the cis-trans-isomerization of peptide bonds in proline-containing peptides Biomed Biochim Acta 43 1984 1101 1111 (Pubitemid 15221717)
2. X.L. Luo, and H.T. Yu Protein metamorphosis: the two-state behavior of Mad2 Structure 16 2008 1616 1625
3. A. Ramanathan, A.J. Savol, C.J. Langmead, P.K. Agarwal, and C.S. Chennubhotla Discovering conformational sub-states relevant to protein function PLoS One 6 2011 e15827
4. R.G. Smock, and L.M. Gierasch Sending signals dynamically Science 324 2009 198 203
5. G. Fischer Peptidyl-prolyl cis/trans isomerases and their effectors Angew Chem Int Ed 33 1994 1415 1436
6. T. Aumuller, G. Jahreis, G. Fischer, and C. Schiene-Fischer Role of prolyl cis/trans isomers in cyclophilin-assisted pseudomonas syringae AvrRpt2 protease activation Biochemistry 49 2010 1042 1052
7. D.J. Lubin, J.S. Butler, and S.N. Loh Folding of tetrameric p53: oligomerization and tumorigenic mutations induce misfolding and loss of function J Mol Biol 395 2010 705 716
8. G. Fischer, and T Aumuller Regulation of peptide bond cis/trans isomerization by enzyme catalysis and its implication in physiological processes Rev Physiol Biochem Pharmacol 148 2004 105 150
9. G. Finn, and K.P. Lu Phosphorylation-specific prolyl isomerase Pin1 as a new diagnostic and therapeutic target for cancer Curr Cancer Drug Targets 8 2008 223 229 (Pubitemid 351666858)
10. F.T. Bane, J.H. Bannon, S.R. Pennington, G. Campaini, D.C. Williams, D.M. Zisterer, and M.M. McGee The microtubule-targeting agents, PBOX-6 pyrrolobenzoxazepine 7-(dimethylcarbamoyl) oxy-6-(2-naphthyl) pyrrolo-2,1-d (1,5)-benzoxazepine and paclitaxel, induce nucleocytoplasmic redistribution of the peptidyl-prolyl isomerases, cyclophilin A and Pin1, in malignant hematopoietic cells J Pharmacol Exp Ther 329 2009 38 47
11. N. Shulga, R. Wilson-Smith, and J.G. Pastorino Sirtuin-3 deacetylation of cyclophilin D induces dissociation of hexokinase II from the mitochondria J Cell Sci 123 2010 894 902
12. M. Lammers, H. Neumann, J.W. Chin, and L.C. James Acetylation regulates cyclophilin A catalysis, immunosuppression and HIV isomerization Nat Chem Biol 6 2010 331 337
13. A.V. Hafner, J. Dai, A.P. Gomes, C.Y. Xiao, C.M. Palmeira, A. Rosenzweig, and D.A. Sinclair Regulation of the mPTP by SIRT3-mediated deacetylation of CypD at lysine 166 suppresses age-related cardiac hypertrophy Aging 2 2010 914 923
14. P. Chaurand, M.A. Rahman, T. Hunt, J.A. Mobley, G. Gu, J.C. Latham, R.M. Caprioli, and S. Kasper Monitoring mouse prostate development by profiling and imaging mass spectrometry Mol Cell Proteomics 7 2008 411 423 (Pubitemid 351298452)
15. T. Stewart, S.C. Tsai, H. Grayson, R. Henderson, and G. Opelz Incidence of de-novo breast cancer in women chronically immunosuppressed after organ transplantation Lancet 346 1995 796 798
16. M. Kohjima, M. Enjoji, N. Higuchi, K. Kotoh, M. Kato, R. Takayanagi, and M. Nakamuta NIM811, a nonimmunosuppressive cyclosporine analogue, suppresses collagen production and enhances collagenase activity in hepatic stellate cells Liver Int 27 2007 1273 1281 (Pubitemid 47543157)
17. M. Hojo, T. Morimoto, M. Maluccio, T. Asano, K. Morimoto, M. Lagman, T. Shimbo, and M. Suthanthiran Cyclosporine induces cancer progression by a cell-autonomous mechanism Nature 397 1999 530 534
18. K.G. Norman, J.A. Canter, M.J. Shi, G.L. Milne, J.D. Morrow, and J.E. Sligh Cyclosporine A suppresses keratinocyte cell death through MPTP inhibition in a model for skin cancer in organ transplant recipients Mitochondrion 10 2010 94 101
19. R.A. Eliseev, J. Malecki, T. Lester, Y. Zhang, J. Humphrey, and T.E. Gunter Cyclophilin D interacts with Bcl2 and exerts an anti-apoptotic effect J Biol Chem 284 2009 9692 9699
20. L.E. Fried, and J.L. Arbiser Honokiol, a multifunctional antiangiogenic and antitumor agent Antooxid Redox Signal 11 2009 1139 1148
21. C.V. Clevenger, S.L. Gadd, and J.M. Zheng New mechanisms for PRLr action in breast cancer Trends Endocrinol Metab 20 2009 223 229
22. F. Fang, A.J. Flegler, P. Du, S. Lin, and C.V. Clevenger Expression of cyclophilin B is associated with malignant progression and regulation of genes implicated in the pathogenesis of breast cancer Am J Pathol 174 2009 297 308
23. F. Fang, J. Zheng, T.L. Galbaugh, A.A. Fiorillo, E.E. Hjort, X. Zeng, and C.V. Clevenger Cyclophilin B as a co-regulator of prolactin-induced gene expression and function in breast cancer cells J Mol Endocrinol 44 2010 319 329
24. K. Bauer, A.K. Kretzschmar, H. Cvijic, C. Blumert, D. Loffler, K. Brocke-Heidrich, C. Schiene-Fischer, G. Fischer, A. Sinz, and C.V. Clevenger Cyclophilins contribute to Stat3 signaling and survival of multiple myeloma cells Oncogene 28 2009 2784 2795
25. S. Periyasamy, T. Hinds, L. Shemshedini, W. Shou, and E.R. Sanchez FKBP51 and Cyp40 are positive regulators of androgen-dependent prostate cancer cell growth and the targets of FK506 and cyclosporin A Oncogene 29 2010 1691 1701
26. J. Chen, M. Watanabe, P. Huang, M. Sakaguchi, K. Ochiai, Y. Nasu, M. Ouchida, N.H. Huh, K. Shimizu, and Y. Kashiwakura REIC/Dkk-3 stable transfection reduces the malignant phenotype of mouse prostate cancer RM9 cells Int J Mol Med 23 2009 789 794
27. S. Obchoei, S. Wongkhan, C. Wongkham, M. Li, Q.Z. Yao, and C.Y. Chen Cyclophilin A: potential functions and therapeutic target for human cancer Med Sci Monitor 15 2009 1234-1010
28. J. Lee, and S.S. Kim An overview of cyclophilins in human cancers J Int Med Res 38 2010 1561 1574
29. Z.Y. Li, X. Zhao, S.J. Bai, Z. Wang, L.J. Chen, Y.Q. Wei, and C.H. Huang Proteomics identification of cyclophilin A as a potential prognostic factor and therapeutic target in endometrial carcinoma Mol Cell Proteomics 7 2008 1810 1823
30. K. Obama, T. Kato, S. Hasegawa, S. Satoh, Y. Nakamura, and Y. Furukawa Overexpression of peptidyl-prolyl isomerase-like 1 is associated with the growth of colon cancer cells Clin Cancer Res 12 2006 70 76 (Pubitemid 43166178)
31. D.H. Huo, L.N. Yi, and J. Yang Interaction with Ppil3 leads to the cytoplasmic localization of apoptin in tumor cells Biochem Biophys Res Commun 372 2008 14 18
32. K.J. Choi, Y.J. Piao, M.J. Lim, J.H. Kim, J. Ha, W. Choe, and S.S. Kim Overexpressed cyclophilin A in cancer cells renders resistance to hypoxia- and cisplatin-induced cell death Cancer Res 67 2007 3654 3662 (Pubitemid 46762150)
33. N. Baum, C. Schiene-Fischer, M. Frost, M. Schumann, K. Sabapathy, O. Ohlenschlager, F. Grosse, and B. Schlott The prolyl cis/trans isomerase cyclophilin 18 interacts with the tumor suppressor p53 and modifies its functions in cell cycle regulation and apoptosis Oncogene 44 2009 3915 3925
34. J. Lee Novel combinational treatment of cisplatin with cyclophilin A inhibitors in human heptocellular carcinomas Arch Pharm Res 33 2010 1401 1409
35. X. Han, S.H. Yoon, Y. Ding, T.G. Choi, W.J. Choi, Y.H. Kim, Y.J. Kim, Y.B. Huh, J. Ha, and S.S. Kim Cyclosporin A and sanglifehrin A enhance chemotherapeutic effect of cisplatin in C6 glioma cells Oncol Rep 23 2010 1053 1062
36. J. Li, L.F. Peng, L.S. Wu, Y.H. Kuang, J.A. Su, M. Yi, X.L. Hu, D. Li, H.F. Xie, and T. Kanekura Depletion of CD147 sensitizes human malignant melanoma cells to hydrogen peroxide-induced oxidative stress J Dermatol Sci 58 2010 204 210
37. H. Peng, S. Vijayakumar, C. Schiene-Fischer, H. Li, J.M. Purkerson, M. Malesevic, J. Liebscher, Q. Al-Awqati, and G.J. Schwartz Secreted cyclophilin A, a peptidyl-prolyl cis-trans isomerase, mediates matrix assembly of hensin, a protein implicated in epithelial differentiation J Biol Chem 284 2009 6465 6475
38. S.K. Payeli, C. Schiene-Fischer, J. Steffel, G.G. Camici, L. Rozenberg, T.F. Luscher, and F.C. Tanner Cyclophilin A differentially activates monocytes and endothelial cells role of purity, activity, and endotoxin contamination in commercial preparations Atherosclerosis 197 2007 564 571 (Pubitemid 351417900)
39. H. Pan, C. Luo, R. Li, A. Qiao, L. Zhang, M. Mines, A.M. Nyanda, J. Zhang, and G.H. Fan Cyclophilin a is required for CXCR4-mediated nuclear export of heterogeneous nuclear ribonucleoprotein a2, activation and nuclear translocation of ERK1/2, and chemotactic cell migration J Biol Chem 283 2008 623 637
40. L. Bao, A. Kimzey, G. Sauter, J.M. Sowadski, K.P. Lu, and D.G. Wang Prevalent overexpression of prolyl isomerase Pin1 in human cancers Am J Pathol 164 2004 1727 1737 (Pubitemid 38529775)
41. X. Tan, F. Zhou, J. Wan, J. Hang, Z. Chen, B. Li, C. Zhang, K. Shao, P. Jiang, and S. Shi Pin1 expression contributes to lung cancer: prognosis and carcinogenesis Cancer Biol Ther 9 2010 111 119
42. K.P. Lu, and X.Z. Zhou The prolyl isomerase PIN1: a pivotal new twist in phosphorylation signalling and disease Nat Rev Mol Cell Biol 8 2007 904 916 (Pubitemid 47622559)
43. A. Ryo, Y.C. Liou, G. Wulf, M. Nakamura, S.W. Lee, and K.P. Lu PIN1 is an E2F target gene essential for Neu/Ras-induced transformation of mammary epithelial cells Mol Cell Biol 22 2002 5281 5295 (Pubitemid 34755742)
44. Y. Zheng, Y. Xia, D. Hawke, M. Halle, M.L. Tremblay, X. Gao, X.Z. Zhou, K. Aldape, M.H. Cobb, and K. Xie FAK phosphorylation by ERK primes Ras-induced tyrosine dephosphorylation of FAK mediated by PIN1 and PTP-PEST Mol Cell 35 2009 11 25
45. D.A. Ritt, D.M. Monson, S.I. Specht, and D.K. Morrison Impact of feedback phosphorylation and Raf heterodimerization on normal and mutant B-Raf signaling Mol Cell Biol 30 2010 806 819
46. A. Nakano, D. Koinuma, K. Miyazawa, T. Uchida, M. Saitoh, M. Kawabata, J. Hanai, H. Akiyama, M. Abe, and K. Miyazono Pin1 down-regulates transforming growth factor-beta (TGF-beta) signaling by inducing degradation of Smad proteins J Biol Chem 284 2009 6109 6115
47. I. Matsuura, K.N. Chiang, C.Y. Lai, D. He, G. Wang, R. Ramkumar, T. Uchida, A. Ryo, K.P. Lu, and F. Liu Pin1 promotes transforming growth factor-beta-induced migration and invasion J Biol Chem 285 2010 1754 1764
48. R. Pang, T.K. Lee, R.T. Poon, S.T. Fan, K.B. Wong, Y.L. Kwong, and E. Tse Pin1 interacts with a specific serine-proline motif of hepatitis B virus X-protein to enhance hepatocarcinogenesis Gastroenterology 132 2007 1088 1103 (Pubitemid 46440863)
49. S.J. Jeong, A. Ryo, and N. Yamamoto The prolyl isomerase Pin1 stabilizes the human T-cell leukemia virus type 1 (HTLV-1) Tax oncoprotein and promotes malignant transformation Biochem Biophys Res Commun 381 2009 294 299
50. J.M. Peloponese Jr., J. Yasunaga, T. Kinjo, K. Watashi, and K.T. Jeang Peptidylproline cis-trans-isomerase Pin1 interacts with human T-cell leukemia virus type 1 tax and modulates its activation of NF-kappaB J Virol 83 2009 3238 3248
51. A. Rustighi, L. Tiberi, A. Soldano, M. Napoli, P. Nuciforo, A. Rosato, F. Kaplan, A. Capobianco, S. Pece, and P.P. Di Fiore The prolyl-isomerase Pin1 is a Notch1 target that enhances Notch1 activation in cancer Nat Cell Biol 11 2009 133 142
52. H. Zheng, H. You, X.Z. Zhou, S.A. Murray, T. Uchida, G. Wulf, L. Gu, X. Tang, K.P. Lu, and Z.X. Xiao The prolyl isomerase Pin1 is a regulator of p53 in genotoxic response Nature 419 2002 849 853 (Pubitemid 35238572)
53. P. Zacchi, M. Gostissa, T. Uchida, C. Salvagno, F. Avolio, S. Volinia, Z. Ronai, G. Blandino, C. Schneider, and G. Del Sal The prolyl isomerase Pin1 reveals a mechanism to control p53 functions after genotoxic insults Nature 419 2002 853 857 (Pubitemid 35238573)
54. D. Siepe, and S. Jentsch Prolyl isomerase Pin1 acts as a switch to control the degree of substrate ubiquitylation Nat Cell Biol 11 2009 967 972
55. F. Mantovani, F. Tocco, J. Girardini, P. Smith, M. Gasco, X. Lu, T. Crook, and G. Del Sal The prolyl isomerase Pin1 orchestrates p53 acetylation and dissociation from the apoptosis inhibitor iASPP Nat Struct Mol Biol 14 2007 912 920 (Pubitemid 47525182)
56. F. Mantovani, M. Gostissa, L. Collavin, and G. Del Sal KeePin' the p53 family in good shape Cell Cycle 3 2004 905 911 (Pubitemid 40179470)
57. G.G. Xu, and F.A. Etzkorn Pin1 as an anticancer drug target Drug News Perspect 22 2009 399 407
58. E.S. Yeh, and A.R. Means PIN1, the cell cycle and cancer Nat Rev Cancer 7 2007 381 388 (Pubitemid 46652482)